ENTX

Entera Bio Ltd.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$3.22

Price (1 Year)

$3.23 $1.04

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %0.8 / %30
Non-compliant assets / Total market cap %0 / %30
Non-compliant revenue / Total income %100 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It develops EB613, an oral teriparatide, which completed the Phase II clinical trial for the treatment of osteoporosis and Phase I clinical trial for the treatment of stress fractures.

Website

Analysis (Turkish): ENTX Hissesi Caiz mi, Helal mi? Entera Bio Ltd. Katılım Analizi